Quantification of PCR products using microparticles and flow cytometry

Area of Science:

• Biomarker analysis
• Molecular diagnostics
• Flow cytometry

Background:

• Genetic biomarker analysis is crucial for clinical diagnostics, including disease identification and pathogen detection.
• Polymerase chain reaction (PCR), microparticles, and flow cytometry offer a universal platform for routine biomarker analysis.

Purpose of the Study:

• To demonstrate the applicability and flexibility of the PCR-microparticle-flow cytometry platform for various diagnostic applications.
• To evaluate the impact of laser wavelength and power on assay sensitivity.

Main Methods:

• Utilized a universal platform combining PCR, microparticles, and flow cytometry for biomarker analysis.
• Applied the technology to quantify interferon gamma (IFNG) mRNA and detect cytomegalovirus (CMV) infections.
• Performed multiplex PCR for analyzing multiple genetic targets simultaneously.
• Investigated the use of a green laser (532 nm) versus a conventional blue laser (488 nm) to assess sensitivity.

Main Results:

• Successfully quantified IFNG mRNA in irradiated white blood cells.
• Detected latent cytomegalovirus (CMV) infections.
• Demonstrated multiplex PCR capability, including identifying deletions in a hybrid cell line with an internal control (RAB1).
• Showed that a 532 nm green laser significantly increased assay sensitivity compared to a 488 nm blue laser.

Conclusions:

• The PCR-microparticle-flow cytometry platform is suitable for clinical routine diagnostics.
• The technology meets essential criteria including sensitivity, specificity, reproducibility, and automatibility.
• Enhanced sensitivity achieved with a green laser improves diagnostic potential.